Exane Derivatives’s Vicor VICR Stock Holding History

Exane Derivatives’s Portfolio VICR Stock Details VICR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,691	Closed	-$119K	–	983
2022 Q1	$119K	Buy	+1,691	New	+$152K	0.03%	444
2021 Q4	–	Sell	-2,227	Closed	-$299K	–	1034
2021 Q3	$299K	Sell	2,227 -14	-0.6%	-$1.67K	0.07%	288
2021 Q2	$240K	Buy	2,241 +87	+4%	+$7.74K	0.05%	351
2021 Q1	$183K	Sell	2,154 -1,025	-32%	-$96.5K	0.05%	314
2020 Q4	$293K	Buy	+3,179	New	+$267K	0.09%	248

Other funds holding VICR

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Exane Derivatives's VICR Position: Q2 2022 in Review

Exane Derivatives sold out of Vicor (VICR) in Q2 2022, closing a stake of 1,691 shares — an estimated $119K sold.

Exane Derivatives first reported a position in VICR in Q4 2020 and held it in 5 quarters. The position peaked at $299K in Q3 2021. 195 funds tracked by Wall St. Rank hold VICR as of Q2 2022.

Exane Derivatives reported no remaining Vicor position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 1,691 Vicor shares in Q2 2022, an estimated $119K.
Exane Derivatives first reported a position in Vicor in Q4 2020 and held it in 5 quarters.
Exane Derivatives's Vicor position peaked at $299K in Q3 2021.
195 funds tracked by Wall St. Rank held Vicor as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.